EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Protein Profiling Identifies Biomarkers for Predicting Disease Severity in Anti-NMDAR Encephalitis

Shufang Zhao, Fang Xu, Lili Cui, Weibi Chen, Gang Liu, Huimin Zhang, Dawei Shan iD, Shuting Chai, Le Yang, Guoliang Chai, Dongshan Wan, Yan Zhang

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27177577 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Shufang Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xuanwu Hospital Capital Medical University, National Center for Neurological Disorders, Beijing 100053, China. Hauptthemen laut MEDLINE: Biomarkers, Anti-N-Methyl-D-Aspartate Receptor Encephalitis, Proteomics. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Municipal Administration of Hospitals, Research Ward Excellence Program of Beijing Healthcare, Beijing Municipal Administration of Hospitals Incubating Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a severe autoimmune neurological disorder characterized by pathogenic antibodies against the NMDAR. A systematic protein profiling approach is warranted to identify biomarkers capable of predicting disease status. An Olink proximity extension assay (PEA) profiled 91 inflammation-related proteins from anti-NMDAR encephalitis patients. Disease severity or prognosis were assessed by CASE score or mRS score at 6-month follow-up. Patients were stratified into distinct molecular clusters using unsupervised clustering. Logistic regression models incorporating selected biomarkers were developed to predict disease severity and prognosis, followed by absolute quantification using ELISA. Patients were classified into four consensus clusters. Clusters 1 and 2 corresponded to the mild group, while Cluster 3 represented the severe group, consistent with CASE score above 6. Cluster 4 showed heterogeneous clinical features. Elevated serum levels of IL-10, IL-6, and SIRT2, as well as increased CSF levels of CXCL10, CXCL11, and MMP10, were positively associated with severe disease. Conversely, several proteins including LTA and CCL11, CCL8, TGFB1, CXCL6 were associated with severe disease or unfavorable 6-month outcomes. A logistic regression model combining serum CXCL6 and CCL11 with CSF MMP10 achieved an area under the curve (AUC) of 0.95 for predicting disease severity. Serum CCL11 alone showed predictive value for 6-month prognosis, with an AUC of 0.79. These findings delineate distinct protein signatures associated with clinical heterogeneity of anti-NMDAR encephalitis. Prediction models incorporating multiple biomarkers may provide an approach for disease severity stratification and prognosis forecast.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersAnti-N-Methyl-D-Aspartate Receptor EncephalitisProteomicsHumansFemaleMalePrognosisSeverity of Illness IndexAdultYoung Adult

Stichwörter der Autor:innen

anti-NMDAR encephalitisautoimmune encephalitisprotein biomarkersproximity extension assay (PEA)

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Neurology, Xuanwu Hospital Capital Medical University, National Center for Neurological Disorders, Beijing 100053, China.
  • Institute of Sleep and Consciousness Disorders, Beijing Institute of Brain Disorders, Collaborative Innovation Center for Brain Disorders, Capital Medical University, Beijing 100069, China.

ORCID-Profile: Dawei Shan

Förderung

  • Beijing Municipal Administration of Hospitals
  • Research Ward Excellence Program of Beijing Healthcare
  • Beijing Municipal Administration of Hospitals Incubating Program
  • Research Ward Excellence Program of Beijing Healthcare Commission

Zitieren

APA

Zhao, S., Xu, F., Cui, L., Chen, W., Liu, G., Zhang, H., Shan, D., Chai, S., Yang, L., Chai, G., Wan, D., & Zhang, Y. (2026). Protein Profiling Identifies Biomarkers for Predicting Disease Severity in Anti-NMDAR Encephalitis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177577

Vancouver

Zhao S, Xu F, Cui L, Chen W, Liu G, Zhang H, et al. Protein Profiling Identifies Biomarkers for Predicting Disease Severity in Anti-NMDAR Encephalitis. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177577

BibTeX
@article{Zhao2026,
  author = {Zhao, Shufang and Xu, Fang and Cui, Lili and Chen, Weibi and Liu, Gang and Zhang, Huimin and Shan, Dawei and Chai, Shuting and Yang, Le and Chai, Guoliang and Wan, Dongshan and Zhang, Yan},
  title = {Protein Profiling Identifies Biomarkers for Predicting Disease Severity in Anti-NMDAR Encephalitis},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27177577}
}
Kostenlos starten →